Polaris Capital Management, LLC

Position in CYTK — Cytokinetics Inc

CIK 1316926 BOSTON, MA

Position in CYTK

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$22,737,211

New position

Shares Held

266,900

first reported quarter

Ownership

0.192%

of shares outstanding

% of Portfolio

2.18%

of 13F equity value

Holder Rank

#82

of 477 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Polaris Capital Management, LLC holds $104,753,532 across 4 Biotechnology names. CYTK ranks #2 (21.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JAZZ	Jazz Pharmaceuticals plc	328,966	$79,270,937
2	CYTK	Cytokinetics Inc This page	266,900	$22,737,211
3	EXEL	Exelixis, Inc.	26,300	$1,430,983
4	HRMY	Harmony Biosciences Holdings, Inc.	36,100	$1,314,401

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$22,737,211	266,900	—	Shares	Sole	2026-07-27
No filing history on record for this holder in this stock.